Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
Logo Image
|Articles|June 15, 2015

BioPharm International

  • BioPharm International-06-15-2015
  • Volume 2015 eBook
  • Issue 1

Biopharma Advances Demand Specialized Expertise

Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.

 

The approval of the first biosimilar in the United States, as well as continuing consolidation in the biopharma and contract development and manufacturing markets, are just two indicators of the ongoing evolution of biopharmaceutical development. Representatives of contract service providers shared observations, trends and projections with BioPharm International.

 

Download

BioPharm International’s 2015 Outsourcing Resources eBook

.

 

 

 

 

 

 

Articles in this issue

over 11 years ago

QRM Tools for Contract Biomanufacturing

over 11 years ago

Fill/Finish Trends

over 11 years ago

Protecting Intellectual Property in Engagements with CMOs

over 11 years ago

Taking a “Development-by-Design” Approach to Cell Therapies

Related to this article

View more
The Promise of Microgravity for R&D and Manufacturing
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.
Read more